| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027871A2 Novel anticancer cathepsin preparation and anticancer agent for combination therapy against cancer using the same |
| 02/25/2009 | EP2027870A1 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin |
| 02/25/2009 | EP2027869A2 Neuregulin in the treatment of heart diseases |
| 02/25/2009 | EP2027868A1 Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027857A2 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/25/2009 | EP2027296A2 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 02/25/2009 | EP2027144A1 Macrocyclic compounds as antiviral agents |
| 02/25/2009 | EP2026836A2 Peptide therapy |
| 02/25/2009 | EP2026835A1 Nasal and buccal compositions for controlling snoring |
| 02/25/2009 | EP2026833A2 Methods for inhibiting cardiac pai-1 |
| 02/25/2009 | EP2026832A2 Cladribine regimen for treating multiple sclerosis |
| 02/25/2009 | EP2026831A2 Methods and compositions for treating and preventing peripheral nerve damage |
| 02/25/2009 | EP2026830A2 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis |
| 02/25/2009 | EP2026822A1 Topical treatment for diseases of eye surface |
| 02/25/2009 | EP1753478B1 Medical device comprising a biologically active agent |
| 02/25/2009 | EP1556020B1 Use of cgrp antagonist compounds for treatment of psoriasis |
| 02/25/2009 | EP1545636A4 Hemostatic dressing |
| 02/25/2009 | EP1471920B1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/25/2009 | EP1459758B1 Cofilin for promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 02/25/2009 | EP1381361B1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/25/2009 | EP1317289B1 Dominant negative PLB mutant for use in treating cardiac disease |
| 02/25/2009 | EP1254106B1 Calcilytic compounds |
| 02/25/2009 | EP1247532B1 Composition promoting lacrimal secretion |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1169050B1 Ocular treatment using cyclosporin-a derivatives |
| 02/25/2009 | EP1075277B1 Methods for detecting and inhibiting angiogenesis |
| 02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
| 02/25/2009 | EP1017721B1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/25/2009 | EP0896058B1 Novel semaphorin z and gene encoding the same |
| 02/25/2009 | EP0871763B1 Method for preparation of type ii collagen |
| 02/25/2009 | EP0852587B1 Synthetic peptides that inhibit il-6 activity |
| 02/25/2009 | EP0833912B1 Novel tgf-beta like cytokine |
| 02/25/2009 | CN101374955A Targeting vector-phospholipid conjugates |
| 02/25/2009 | CN101374950A Improved IL-15 and IL-15R-alpha for expression in mammalian cells |
| 02/25/2009 | CN101374860A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 02/25/2009 | CN101374857A Novel T-helper antigenic determinant (THD) peptides |
| 02/25/2009 | CN101374856A Inhibiting tumor cell invasion, metastasis and angiogenesis |
| 02/25/2009 | CN101374855A Purification and use of a factor for supporting wound healing |
| 02/25/2009 | CN101374544A Enzymes for reduced immunological stress |
| 02/25/2009 | CN101374543A Methods of treating or preventing tissue damage caused by increased blood flow |
| 02/25/2009 | CN101374542A Bovine osteopontin formulations for the improvement of the wound healing process |
| 02/25/2009 | CN101374541A Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 02/25/2009 | CN101374540A Purpose of TPO peptide compound and medicament composition for treating anaemia |
| 02/25/2009 | CN101374539A Prodrugs of ribavirin with improved hepatic delivery |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101374537A MNTF differentiation and growth of stem cells |
| 02/25/2009 | CN101374536A Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 02/25/2009 | CN101374522A ANG2 and VEGF inhibitor combinations |
| 02/25/2009 | CN101374520A Remedy for diabetic |
| 02/25/2009 | CN101372513A SG fusion protein |
| 02/25/2009 | CN101372512A Anticoagulated blood polypeptides and uses thereof |
| 02/25/2009 | CN101372511A Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 02/25/2009 | CN101372510A Calcium ion activated chloride ion channel and use thereof |
| 02/25/2009 | CN101372508A Polypeptide and use thereof |
| 02/25/2009 | CN101372507A Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof |
| 02/25/2009 | CN101371925A Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
| 02/25/2009 | CN101371921A Instant lyophilized fibrinogen and fibrin ferment formulation composition, preparation method and use thereof |
| 02/25/2009 | CN101371920A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 02/25/2009 | CN101371919A Mouse model with zinc finger protein ZBTB20 specific gene knockout in pancreatic gland beta cell and use |
| 02/25/2009 | CN101371918A Novel use of oxidation resistance dipeptide in fish extract polypeptide |
| 02/25/2009 | CN101371917A Brain protein hydrolysate sodium chloride injection and preparation method thereof |
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/25/2009 | CN100463917C Reductive alkylation of glycopeptide antibiotics |
| 02/25/2009 | CN100463697C Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant external ointments |
| 02/25/2009 | CN100463694C Virus coat protein/receptor chimeras and methods of use |
| 02/25/2009 | CN100463693C Interferon oculentum |
| 02/25/2009 | CN100463672C Method for preparing large quantity of micro-capsule |
| 02/24/2009 | US7495147 Nucleic acids comprising the neuregulin 1 gene (NRG1); use in diagnosis and treatment of schizophrenia; drug screening |
| 02/24/2009 | US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/24/2009 | US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein |
| 02/24/2009 | US7495089 Inhibit endothelial cell proliferation, angiogenesis and cause tumor regression; antiproliferative, anticarcinogenic and antitumor agents |
| 02/24/2009 | US7495087 Using interkeukin mutein as therapeutic in treatment of thrombocytopenia |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495082 Antibodies to PRO4349 polypeptides |
| 02/24/2009 | US7495079 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 02/24/2009 | US7495078 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 02/24/2009 | US7495077 Homogeneous preparations of IL-28 and IL-29 |
| 02/24/2009 | US7495076 Methods of increasing bone density/preventing osteoporosis, of reducing joint pain and/or joint deterioration from osteoarthritis, degenerative joint disease, joint defect, and rheumatoid arthritis; maximum and consistent bioavailability |
| 02/24/2009 | US7495075 Growth differentiation factor-16 |
| 02/24/2009 | US7495074 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 02/24/2009 | US7495071 Antiproliferative peptides and antibodies for their detection |
| 02/24/2009 | US7495070 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders |
| 02/24/2009 | US7495068 Antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 02/24/2009 | US7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 02/24/2009 | US7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 02/24/2009 | US7494984 Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
| 02/24/2009 | US7494981 Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors |
| 02/24/2009 | US7494980 administering a decapeptide of the sequence NH2-Iys-lys-val-val-phe-lys-val-lys-phe-lys-CONH2; biofilm formation inhibition; anticaries agent |
| 02/24/2009 | US7494979 Method for treating congestive heart failure and other disorders |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494976 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
| 02/24/2009 | US7494975 A polyanion selected from a heparin, a dextran, a pentosan, resobene, curdian sulfate, or 2-naphthalene sulfonate polymer and a CD4 polypeptide with a beta-hairpin confirmation; blocking HIV interaction with coreceptors |
| 02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
| 02/24/2009 | US7494972 Administering a polypeptide comprising a V-type immunoglobulin domain followed by two C-type domains of soluble human receptor for advanced glycation endproduct (sRAGE) by injection, liposome, mouth, eye, nose or topically |
| 02/24/2009 | US7494971 Pharmaceutical preparations and medicines capable of generating, and/or containing, thrombin |